HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era
Open Access
- 6 June 2016
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 7, 190
Abstract
The ZVITAMBO trial recruited 14110 mother-infant pairs to a randomised controlled trial of vitamin A between 1997-2000, before the availability of antiretroviral therapy for HIV prophylaxis or treatment in Zimbabwe. The HIV status of mothers and infants was well characterised through 1-2 years of follow-up, leading to the largest cohort to date of HIV-exposed uninfected (HEU) infants (n=3135), with a suitable comparison group of HIV-unexposed infants (n=9510). Here, we draw on 10 years of published findings from the ZVITAMBO trial. HEU infants had increased morbidity compared to HIV-unexposed infants, with 50% more hospitalisations in the neonatal period and 30% more sick clinic visits during infancy, particularly for skin infections, lower respiratory tract infections and oral thrush. HEU children had 3.9-fold and 2.0-fold higher mortality than HIV-unexposed children during the first and second years of life, respectively, most commonly due to acute respiratory infections, diarrhoea/dysentery, malnutrition, sepsis and meningitis. Infant morbidity and mortality was strongly related to maternal HIV disease severity, with a risk that remained until maternal CD4 counts were >800 cells/uL. HEU infants were more likely to be premature and small-for-gestational age than HIV-unexposed infants, and had more postnatal growth failure. Here, we propose a conceptual framework to explain the increased risk of infectious morbidity, mortality and growth failure among HEU infants, hypothesizing that immune activation and inflammation are key drivers of both infection susceptibility and growth failure. Future studies should further dissect the causes of infection susceptibility and growth failure, and determine the impact of ART and co-trimoxazole on outcomes of this vulnerable group of infants in the current era.Keywords
Funding Information
- Wellcome Trust (108065/Z/15/Z)
- United States Agency for International Development (Cooperative agreement number HRN-A-00-97-00015-00 between Johns Hopkins University and the Office of Health and Nutrition – USAID)
- Bill and Melinda Gates Foundation
- Rockefeller Foundation
- BASF
- National Institute for Health Research
This publication has 113 references indexed in Scilit:
- Risk of childhood undernutrition related to small-for-gestational age and preterm birth in low- and middle-income countriesInternational Journal of Epidemiology, 2013
- Specific antibodies against vaccine-preventable infections: a mother–infant cohort studyBMJ Open, 2013
- Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, UgandaPublic Health Nutrition, 2013
- Highly Active Antiretroviral Therapy and Adverse Birth Outcomes Among HIV-Infected Women in BotswanaThe Journal of Infectious Diseases, 2012
- Human Cytomegalovirus Infant Infection Adversely Affects Growth and Development in Maternally HIV-Exposed and Unexposed Infants in ZambiaClinical Infectious Diseases, 2012
- Increased Risk of Preterm Delivery Among HIV-Infected Women Randomized to Protease Versus Nucleoside Reverse Transcriptase Inhibitor-Based HAART During PregnancyThe Journal of Infectious Diseases, 2011
- Markers of Inflammation, Coagulation, and Renal Function Are Elevated in Adults with HIV InfectionThe Journal of Infectious Diseases, 2010
- Human cytomegalovirus elicits fetal γδ T cell responses in uteroJournal of Experimental Medicine, 2010
- Milk Mysteries: Why Are Women Who Exclusively Breast-Feed Less Likely to Transmit HIV during Breast-Feeding?Clinical Infectious Diseases, 2010
- Microbial translocation is a cause of systemic immune activation in chronic HIV infectionNature Medicine, 2006